Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Global Blood Therapeutics
Global Blood Therapeutics
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
Wed, 11/27/19 - 12:39 pm
FDA
Vertex Pharmaceuticals
Trikafta
Novartis
Adakveo
Alnylam
Givlaari
BeiGene
Brukinsa
Global Blood Therapeutics
Oxbryta
drug approvals
Global Blood’s Sickle Cell Drug Wins FDA Approval Ahead of Schedule
Xconomy
Mon, 11/25/19 - 10:14 pm
Global Blood Therapeutics
FDA
sickle cell disease
voxelotor
Oxbryta
Global Blood Therapeutics Goes Head to Head With Novartis On Sickle Cell
Motley Fool
Sun, 11/24/19 - 11:26 pm
Global Blood Therapeutics
voxelotor
Novartis
Adakveo
sickle cell disease
2 Biotechs With Approaching Drug Approvals
Motley Fool
Sun, 10/13/19 - 11:30 pm
drug approvals
drug launches
FDA
voxelotor
Global Blood Therapeutics
Immunomedics
sacituzumab govitecan
Why Global Blood Therapeutics Stock Jumped 10.9% Today
Motley Fool
Thu, 09/5/19 - 08:26 pm
Global Blood Therapeutics
FDA
voxelotor
sickle cell disease
GBT sickle cell trial hits endpoint ahead of NDA filing
Fierce Biotech
Fri, 06/14/19 - 10:06 am
Global Blood Therapeutics
sickle cell disease
FDA
voxelotor
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts
Yahoo/Benzinga
Sun, 06/9/19 - 01:36 pm
ADA
Merck
Keytruda
NGM Biopharmaceuticals
NGM313/MK-3655
Corbus Pharmaceuticals
Nektar
Galapagos
Kezar Life Sciences
Kura Oncology
Bluebird Bio
BeiGene
Global Blood Therapeutics
Blueprint Medicines
Regeneron
Arqule
Sunesis
Sutro BioPharma
Incyte
Geron
Forty Seven
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Fri, 02/1/19 - 10:36 pm
Biogen
Bluebird Bio
Global Blood Therapeutics
Aimmune Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
Upcoming events – Vertex awaits triplet data and GBT seeks approval for approval
EP Vantage
Sat, 11/17/18 - 12:49 pm
Vertex Pharma
cystic fibrosis
Symdeko
Kalydeco
Global Blood Therapeutics
voxelotor
sickle cell disease
Once lauded for its clinical success, Roche casts off cardio program inclacumab for a mere $2M to Global Blood Therapeutics
Endpoints
Thu, 08/23/18 - 10:11 am
Roche
inclacumab
Global Blood Therapeutics
GBT touts positive sickle cell trial, but shares yo-yo as investors mull data
Fierce Biotech
Wed, 06/27/18 - 12:01 pm
Global Blood Therapeutics
sickle cell disease
voxelotor
clinical trials
The new Biotech Scorecard: 10 make-or-break industry events for the fourth quarter
Stat
Tue, 10/3/17 - 11:50 am
biotech
Axovant Sciences
intepirdine
SAGE Therapeutics
brexanolone
AbbVie
risankizumab
Global Blood Therapeutics
GBT-440
DBV Technologies
Viaskin Peanut
Cytokinetics
Amicus Therapeutics
ATB200
Spark Therapeutics
Bluebird Bio
Revance Therapeutics
RT002
Novo Nordisk in Talks to Buy Global Blood Therapeutics
Investopedia
Fri, 03/10/17 - 11:49 am
Novo Nordisk
M&A
Global Blood Therapeutics
Shares in Global Blood climb after positive study results for experimental sickle cell treatment
First Word Pharma
Fri, 06/10/16 - 10:21 am
Global Blood Therapeutics
GBT440
sickle cell disease
10 Biotechs Short Sellers Are Betting Against
Yahoo/Benzinga
Wed, 12/30/15 - 10:40 am
biotech
Global Blood Therapeutics
Clovis Oncology
Epizyme
Bluebird Bio
Puma Biotechnology
Tokai
MannKind
Myriad Genetics
Orexigan
KaloBios
The Big News For Sickle Cell Anemia Is Not Gene Therapy
Forbes
Tue, 12/15/15 - 09:56 am
gene therapy
sickle cell disease
Global Blood Therapeutics
GBT440
ASH scorecard: AbbVie rides high, GBT slips and Celgene settles in
Fierce Biotech
Wed, 12/9/15 - 11:45 am
AbbVie
Celgene
Roche
Global Blood Therapeutics
Sickle cell biotech GBT banks $120M in an above-range IPO
Fierce Biotech
Thu, 08/13/15 - 09:48 am
sickle cell disease
IPOs
Global Blood Therapeutics
Pages
« first
‹ previous
1
2